Drugs / Cylcophosamide
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06748872 Background | Jul 2025 → Dec 2027 expected | gastroesophageal cancer, malignant epithelial tumor of ovary, myxoid liposarcoma, synovial sarcoma | MediGene | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cylcophosamide | “Cylcophosamide and Fludarabine” NCT06748872 ↗ |